Ibusta (Barnidipine Hydrochloride)

• Barnidipine Hydrochloride is indicated for conditions related to elevated blood pressure within the hypertension disease family.
• Essential hypertension: lowers systolic and diastolic blood pressure in patients with primary high blood pressure.
• Primary hypertension: provides sustained antihypertensive effect for adults with non‑secondary hypertension.
• Isolated systolic hypertension: reduces elevated systolic pressure, especially in elderly patients.

• Barnidipine Hydrochloride inhibits L‑type calcium channels in vascular smooth muscle, preventing calcium influx that triggers contraction. This vasodilatory action reduces peripheral vascular resistance, leading to a decrease in arterial blood pressure and improved blood flow without significant negative inotropic effects.

Barnidipine Hydrochloride may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

• Headache: mild to moderate intensity.
• Dizziness or light‑headedness, especially after standing.
• Flushing or warmth sensation.
• Peripheral edema: swelling of ankles or feet.
• Fatigue or general weakness.
• Tachycardia: increased heart rate.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure causing fainting.
• Allergic reactions: rash, itching, or swelling.
• Liver dysfunction: elevated enzymes or jaundice.
• Cardiac conduction disturbances: heart block or arrhythmias.
• Angioedema: swelling of lips, tongue, or airway.
• Renal impairment: sudden decrease in kidney function.

Before initiating therapy with Barnidipine Hydrochloride, consider the following precautions.

• Renal impairment: monitor kidney function and adjust therapy as needed.
• Hepatic impairment: use with caution and observe liver enzymes.
• Elderly patients: start at lower dose and monitor for orthostatic hypotension.
• Concomitant antihypertensives: increased risk of excessive blood pressure lowering.
• Pregnancy and lactation: safety not established; avoid unless clearly needed.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Barnidipine Hydrochloride can interact with several drug classes. Review the following interaction categories.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise plasma levels.
• Other calcium channel blockers: additive vasodilatory effect leading to hypotension.
• Grapefruit juice: can increase drug exposure and risk of adverse events.

Moderate Interactions (Monitor Closely)

• Diuretics: enhanced antihypertensive effect, monitor electrolytes.
• ACE inhibitors or ARBs: combined effect may cause excessive blood pressure drop.
• Beta‑blockers: monitor heart rate and signs of bradycardia.
• NSAIDs: may attenuate antihypertensive response.
• Antidiabetic agents: possible enhancement of glucose‑lowering effect.